Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2021, Issue -, Pages 1-16
Publisher
Hindawi Limited
Online
2021-09-11
DOI
10.1155/2021/6439975
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
- (2021) Hao Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Oxidative stress-driven DR5 upregulation restores TRAIL/Apo2L sensitivity induced by iron oxide nanoparticles in colorectal cancer
- (2020) Yesi Shi et al. BIOMATERIALS
- Large-scale public data reuse to model immunotherapy response and resistance
- (2020) Jingxin Fu et al. Genome Medicine
- Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer
- (2020) Kang Lin et al. Aging-US
- YIPF2 promotes chemotherapeutic agent-mediated apoptosis via enhancing TNFRSF10B recycling to plasma membrane in non-small cell lung cancer cells
- (2020) Yingying Wang et al. Cell Death & Disease
- Colorectal Cancer and Probiotics: Are Bugs Really Drugs?
- (2020) Purushottam Lamichhane et al. Cancers
- Natural killer cells in cancer biology and therapy
- (2020) Song-Yang Wu et al. Molecular Cancer
- Customizing a Tridomain TRAIL Variant to Achieve Active Tumor Homing and Endogenous Albumin-Controlled Release of the Molecular Machine In Vivo
- (2020) Ze Tao et al. BIOMACROMOLECULES
- First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors
- (2020) Ravit Geva et al. CANCER
- Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy
- (2020) Motasem Alkhayyat et al. INFLAMMATORY BOWEL DISEASES
- An antibody-tumor necrosis factor fusion protein that synergizes with oxaliplatin for treatment of colorectal cancer
- (2020) Davor Bajic et al. MOLECULAR CANCER THERAPEUTICS
- Anxiety, Depression, and Colorectal Cancer Survival: Results from Two Prospective Cohorts
- (2020) Claudia Trudel-Fitzgerald et al. Journal of Clinical Medicine
- Development and validation of a prognostic and immunotherapeutically relevant model in hepatocellular carcinoma
- (2020) Yu Wang et al. Annals of Translational Medicine
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells
- (2019) Young-Lan Park et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Pattern, Stage, and Time of Recurrent Colorectal Cancer After Curative Surgery
- (2019) Salman Yousuf Guraya Clinical Colorectal Cancer
- Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
- (2019) Jung Lim Kim et al. Cancers
- Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer
- (2019) Yulong Bao et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function
- (2019) Fanny Polesso et al. JOURNAL OF IMMUNOLOGY
- Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy
- (2019) Michael A. Morse et al. ONCOLOGIST
- SMC1 promotes proliferation and inhibits apoptosis through the NF‑κB signaling pathway in colorectal cancer
- (2019) Jin Li et al. ONCOLOGY REPORTS
- Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway
- (2019) Chao Liu et al. CELL DEATH AND DIFFERENTIATION
- Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I—Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications
- (2018) Esmeralda Celia Marginean et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1
- (2018) Mengmeng Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy
- (2018) Fei Yi et al. TRENDS IN MOLECULAR MEDICINE
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- TNFRSF10C methylation is a new epigenetic biomarker for colorectal cancer
- (2018) Cong Zhou et al. PeerJ
- The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
- (2018) Catherine Dostert et al. PHYSIOLOGICAL REVIEWS
- Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival
- (2017) Bernhard Mlecnik et al. JNCI-Journal of the National Cancer Institute
- The Interplay between Metabolism, PPAR Signaling Pathway, and Cancer
- (2017) Daniele Fanale et al. PPAR Research
- Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival
- (2017) Bernhard Mlecnik et al. JNCI-Journal of the National Cancer Institute
- A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
- (2015) A. K. Nowak et al. ANNALS OF ONCOLOGY
- A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4–ERK5 axis
- (2015) Ling Wu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- PI3K/AKT signaling pathway and cancer: an updated review
- (2014) Miriam Martini et al. ANNALS OF MEDICINE
- β-catenin regulates NF-κB activityviaTNFRSF19 in colorectal cancer cells
- (2014) Simon Schön et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now